Headspace Volatile Organic Compound Profiling of Pleural Mesothelioma and Lung Cancer Cell Lines as Translational Bridge for Breath Research

• Published in: Frontiers in Oncology
• Main Authors: Eline Janssens, Zoë Mol, Lore Vandermeersch, Sabrina Lagniau, Karim Y. Vermaelen, Jan P. van Meerbeeck, Christophe Walgraeve, Elly Marcq, Kevin Lamote
• Format: Article
• Language: English
• Published: Frontiers Media S.A. 2022-05-01
• Subjects: mesothelioma; lung cancer; biomarkers; volatile organic compounds; headspace analysis
• Online Access: https://www.frontiersin.org/articles/10.3389/fonc.2022.851785/full

IntroductionMalignant pleural mesothelioma (MPM) is a lethal cancer for which early-stage diagnosis remains a major challenge. Volatile organic compounds (VOCs) in breath proved to be potential biomarkers for MPM diagnosis, but translational studies are needed to elucidate which VOCs originate from the tumor itself and thus are specifically related to MPM cell metabolism.MethodsAn in vitro model was set-up to characterize the headspace VOC profiles of six MPM and two lung cancer cell lines using thermal desorption-gas chromatography-mass spectrometry. A comparative analysis was carried out to identify VOCs that could discriminate between MPM and lung cancer, as well as between the histological subtypes within MPM (epithelioid, sarcomatoid and biphasic).ResultsVOC profiles were identified capable of distinguishing MPM (subtypes) and lung cancer cells with high accuracy. Alkanes, aldehydes, ketones and alcohols represented many of the discriminating VOCs. Discrepancies with clinical findings were observed, supporting the need for studies examining breath and tumor cells of the same patients and studying metabolization and kinetics of in vitro discovered VOCs in a clinical setting.ConclusionWhile the relationship between in vitro and in vivo VOCs is yet to be established, both could complement each other in generating a clinically useful breath model for MPM.